Synopsis
Synopsis
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Centrophne
2. Dihydrochloride, Trimetazidine
3. Idaptan
4. Trimtazidine Irex
5. Trimetazidine
6. Vasartel
7. Vastarel
1. 13171-25-0
2. 1-(2,3,4-trimethoxybenzyl)piperazine Dihydrochloride
3. Trimetazidine Hydrochloride
4. Kyurinett
5. Trimetazidine Hcl
6. Trimetazidine 2hcl
7. Trimetazidine (dihydrochloride)
8. Yoshimilon
9. Vastarel F
10. 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine Dihydrochloride
11. Trimetazidine Di-hcl
12. Trimetazidine Hydrochloride [jan]
13. Trimetazidine Dihcl
14. Trimethazidine Dihydrochloride
15. Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, Dihydrochloride
16. Mfcd00243086
17. 48v6723z1p
18. Nsc-759317
19. Trimetajust
20. Lubomail
21. Vastarel
22. Yosimilon
23. Piperazine, 1-((2,3,4-trimethoxyphenyl)methyl)-, Dihydrochloride
24. Dsstox_cid_25407
25. Dsstox_rid_80858
26. Dsstox_gsid_45407
27. 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride
28. Adexor
29. Piperazine, 1-((2,3,4-trimethoxyphenyl)methyl)-, Dihydrochloride (9ci)
30. Sr-01000781912
31. Ncgc00016697-01
32. Einecs 236-117-0
33. Cas-13171-25-0
34. Unii-48v6723z1p
35. S 4004
36. Kyurinett (tn)
37. Prestwick_871
38. Schembl580378
39. Chembl3561076
40. Dtxsid1045407
41. Chebi:32262
42. Piperazine, 1-(2,3,4-trimethoxybenzyl)-, Dihydrochloride
43. Hms1569n19
44. Bcp21402
45. Hy-b0968
46. Trimetazidine For System Suitability
47. Trimetazidine Hydrochloride (jp17)
48. Tox21_110568
49. S4543
50. Akos015895369
51. Tox21_110568_1
52. Ab05480
53. Ac-5896
54. Ccg-213960
55. Cs-4453
56. Ks-1125
57. Nsc 759317
58. Ncgc00016697-04
59. Trimetazidine Dihydrochloride [mi]
60. Trimetazidine Hydrochloride [mart.]
61. Trimetazidine Hydrochloride [who-dd]
62. Ft-0630397
63. T2726
64. A25088
65. D01606
66. P10117
67. 2,3,4-trimethoxybenzylpiperazine Dihydrochloride
68. 171t250
69. Sr-01000781912-3
70. Sr-01000781912-4
71. Trimetazidine Dihydrochloride [ep Monograph]
72. W-108326
73. 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine Dihcl
74. Q27259190
75. F2173-1142
76. 1-(2,3,4-trimethoxybenzyl)piperazine Dihydrochloride, 97%
77. Trimetazidine Dihydrochloride 1.0 Mg/ml In Methanol (as Free Base)
78. Trimetazidine For System Suitability, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 339.3 g/mol |
|---|---|
| Molecular Formula | C14H24Cl2N2O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 338.1163980 g/mol |
| Monoisotopic Mass | 338.1163980 g/mol |
| Topological Polar Surface Area | 43 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 259 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
60
PharmaCompass offers a list of Trimetazidine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trimetazidine manufacturer or Trimetazidine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trimetazidine manufacturer or Trimetazidine supplier.
PharmaCompass also assists you with knowing the Trimetazidine API Price utilized in the formulation of products. Trimetazidine API Price is not always fixed or binding as the Trimetazidine Price is obtained through a variety of data sources. The Trimetazidine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Trimetazine dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimetazine dihydrochloride, including repackagers and relabelers. The FDA regulates Trimetazine dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimetazine dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trimetazine dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trimetazine dihydrochloride supplier is an individual or a company that provides Trimetazine dihydrochloride active pharmaceutical ingredient (API) or Trimetazine dihydrochloride finished formulations upon request. The Trimetazine dihydrochloride suppliers may include Trimetazine dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Trimetazine dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trimetazine dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Trimetazine dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Trimetazine dihydrochloride DMFs exist exist since differing nations have different regulations, such as Trimetazine dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trimetazine dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Trimetazine dihydrochloride USDMF includes data on Trimetazine dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trimetazine dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trimetazine dihydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Trimetazine dihydrochloride Drug Master File in Japan (Trimetazine dihydrochloride JDMF) empowers Trimetazine dihydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Trimetazine dihydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Trimetazine dihydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Trimetazine dihydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Trimetazine dihydrochloride Drug Master File in Korea (Trimetazine dihydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Trimetazine dihydrochloride. The MFDS reviews the Trimetazine dihydrochloride KDMF as part of the drug registration process and uses the information provided in the Trimetazine dihydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Trimetazine dihydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Trimetazine dihydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Trimetazine dihydrochloride suppliers with KDMF on PharmaCompass.
A Trimetazine dihydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Trimetazine dihydrochloride Certificate of Suitability (COS). The purpose of a Trimetazine dihydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Trimetazine dihydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Trimetazine dihydrochloride to their clients by showing that a Trimetazine dihydrochloride CEP has been issued for it. The manufacturer submits a Trimetazine dihydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Trimetazine dihydrochloride CEP holder for the record. Additionally, the data presented in the Trimetazine dihydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Trimetazine dihydrochloride DMF.
A Trimetazine dihydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Trimetazine dihydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Trimetazine dihydrochloride suppliers with CEP (COS) on PharmaCompass.
A Trimetazine dihydrochloride written confirmation (Trimetazine dihydrochloride WC) is an official document issued by a regulatory agency to a Trimetazine dihydrochloride manufacturer, verifying that the manufacturing facility of a Trimetazine dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trimetazine dihydrochloride APIs or Trimetazine dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Trimetazine dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Trimetazine dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trimetazine dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trimetazine dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trimetazine dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trimetazine dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trimetazine dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trimetazine dihydrochloride suppliers with NDC on PharmaCompass.
Trimetazine dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trimetazine dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trimetazine dihydrochloride GMP manufacturer or Trimetazine dihydrochloride GMP API supplier for your needs.
A Trimetazine dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Trimetazine dihydrochloride's compliance with Trimetazine dihydrochloride specifications and serves as a tool for batch-level quality control.
Trimetazine dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Trimetazine dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trimetazine dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimetazine dihydrochloride EP), Trimetazine dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimetazine dihydrochloride USP).
